Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo

Curtis L. Cooper, Barbara Phenix, Georgina Mbisa, Julian J. Lum, Karl Parato, Nanci Hawley, Jonathan B. Angel, Andrew David Badley

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

It has been proposed that antiretroviral therapies (ART) possess both antiviral and immunomodulatory activities when used in HIV infected patients. Few studies have addressed whether these putative immunomodulatory effects are also seen in HIV negative patients, for example, when used for post exposure prophylaxis (PEP). We chose to evaluate immunologic function in HIV negative patients who received Nelfinavir and Combivir (AZT and 3TC) as PEP. Lymphocytes from patients taken immediately before, during, and after PEP were analyzed. No changes were seen in absolute or percent CD4 or CD8 T lymphocyte numbers, nor in markers of activation, memory, or co-stimulatory molecules. Surface expression of apoptosis-related ligands and receptors were unaltered, but apoptosis susceptibility was significantly inhibited by PEP (P<0.05). These data confirm in vitro that apoptosis susceptibility is altered by ART, including in HIV-negative patients who take PEP.

Original languageEnglish (US)
Pages (from-to)338-341
Number of pages4
JournalFrontiers in Bioscience
Volume9
StatePublished - 2004

Fingerprint

Post-Exposure Prophylaxis
Apoptosis
HIV
Nelfinavir
Lamivudine
T-cells
Lymphocytes
Antiviral Agents
Therapeutics
Chemical activation
Ligands
Lymphocyte Count
Data storage equipment
Molecules
T-Lymphocytes

Keywords

  • AIDS
  • Antiretrovirals
  • Apoptosis
  • HIV
  • Protease Inhibitors
  • Retrovirus
  • Viurs

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Cooper, C. L., Phenix, B., Mbisa, G., Lum, J. J., Parato, K., Hawley, N., ... Badley, A. D. (2004). Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo. Frontiers in Bioscience, 9, 338-341.

Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo. / Cooper, Curtis L.; Phenix, Barbara; Mbisa, Georgina; Lum, Julian J.; Parato, Karl; Hawley, Nanci; Angel, Jonathan B.; Badley, Andrew David.

In: Frontiers in Bioscience, Vol. 9, 2004, p. 338-341.

Research output: Contribution to journalArticle

Cooper, CL, Phenix, B, Mbisa, G, Lum, JJ, Parato, K, Hawley, N, Angel, JB & Badley, AD 2004, 'Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo', Frontiers in Bioscience, vol. 9, pp. 338-341.
Cooper CL, Phenix B, Mbisa G, Lum JJ, Parato K, Hawley N et al. Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo. Frontiers in Bioscience. 2004;9:338-341.
Cooper, Curtis L. ; Phenix, Barbara ; Mbisa, Georgina ; Lum, Julian J. ; Parato, Karl ; Hawley, Nanci ; Angel, Jonathan B. ; Badley, Andrew David. / Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo. In: Frontiers in Bioscience. 2004 ; Vol. 9. pp. 338-341.
@article{32155b6898fa4b80998f74d4e5152ceb,
title = "Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo",
abstract = "It has been proposed that antiretroviral therapies (ART) possess both antiviral and immunomodulatory activities when used in HIV infected patients. Few studies have addressed whether these putative immunomodulatory effects are also seen in HIV negative patients, for example, when used for post exposure prophylaxis (PEP). We chose to evaluate immunologic function in HIV negative patients who received Nelfinavir and Combivir (AZT and 3TC) as PEP. Lymphocytes from patients taken immediately before, during, and after PEP were analyzed. No changes were seen in absolute or percent CD4 or CD8 T lymphocyte numbers, nor in markers of activation, memory, or co-stimulatory molecules. Surface expression of apoptosis-related ligands and receptors were unaltered, but apoptosis susceptibility was significantly inhibited by PEP (P<0.05). These data confirm in vitro that apoptosis susceptibility is altered by ART, including in HIV-negative patients who take PEP.",
keywords = "AIDS, Antiretrovirals, Apoptosis, HIV, Protease Inhibitors, Retrovirus, Viurs",
author = "Cooper, {Curtis L.} and Barbara Phenix and Georgina Mbisa and Lum, {Julian J.} and Karl Parato and Nanci Hawley and Angel, {Jonathan B.} and Badley, {Andrew David}",
year = "2004",
language = "English (US)",
volume = "9",
pages = "338--341",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",

}

TY - JOUR

T1 - Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo

AU - Cooper, Curtis L.

AU - Phenix, Barbara

AU - Mbisa, Georgina

AU - Lum, Julian J.

AU - Parato, Karl

AU - Hawley, Nanci

AU - Angel, Jonathan B.

AU - Badley, Andrew David

PY - 2004

Y1 - 2004

N2 - It has been proposed that antiretroviral therapies (ART) possess both antiviral and immunomodulatory activities when used in HIV infected patients. Few studies have addressed whether these putative immunomodulatory effects are also seen in HIV negative patients, for example, when used for post exposure prophylaxis (PEP). We chose to evaluate immunologic function in HIV negative patients who received Nelfinavir and Combivir (AZT and 3TC) as PEP. Lymphocytes from patients taken immediately before, during, and after PEP were analyzed. No changes were seen in absolute or percent CD4 or CD8 T lymphocyte numbers, nor in markers of activation, memory, or co-stimulatory molecules. Surface expression of apoptosis-related ligands and receptors were unaltered, but apoptosis susceptibility was significantly inhibited by PEP (P<0.05). These data confirm in vitro that apoptosis susceptibility is altered by ART, including in HIV-negative patients who take PEP.

AB - It has been proposed that antiretroviral therapies (ART) possess both antiviral and immunomodulatory activities when used in HIV infected patients. Few studies have addressed whether these putative immunomodulatory effects are also seen in HIV negative patients, for example, when used for post exposure prophylaxis (PEP). We chose to evaluate immunologic function in HIV negative patients who received Nelfinavir and Combivir (AZT and 3TC) as PEP. Lymphocytes from patients taken immediately before, during, and after PEP were analyzed. No changes were seen in absolute or percent CD4 or CD8 T lymphocyte numbers, nor in markers of activation, memory, or co-stimulatory molecules. Surface expression of apoptosis-related ligands and receptors were unaltered, but apoptosis susceptibility was significantly inhibited by PEP (P<0.05). These data confirm in vitro that apoptosis susceptibility is altered by ART, including in HIV-negative patients who take PEP.

KW - AIDS

KW - Antiretrovirals

KW - Apoptosis

KW - HIV

KW - Protease Inhibitors

KW - Retrovirus

KW - Viurs

UR - http://www.scopus.com/inward/record.url?scp=2542473290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542473290&partnerID=8YFLogxK

M3 - Article

C2 - 14766370

AN - SCOPUS:2542473290

VL - 9

SP - 338

EP - 341

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

ER -